Abstract: An inverter and an integrated platform having the same are provided. The inverter includes a cabinet having a cabinet door; an inverter body arranged in the cabinet; and a heat exchanger arranged on an outer side of the cabinet, where the inverter body has an alternating-current side, and the cabinet door is arranged on the alternating-current side or an opposite side of the alternating-current side of the inverter body.

Abstract: The present disclosure relates to a dissociation reagent for tumor tissues. The dissociation reagent does not contain collagenase or trypsin but further contains hyaluronidase or a mixture of hyaluronidase and DNase I. The present disclosure also relates to use of the dissociation reagent in dispersing tumor tissues and detecting expression level of molecular markers on cell surface by flow cytometry. The dissociation reagent of the present disclosure does not cause degradation of molecular markers on cell surface such as CD8, PD-1, Tim-3, Lag-3 and the like, thus does not affect downstream assays.

Abstract: The present disclosure relates to a dissociation reagent for tumor tissues. The dissociation reagent does not contain collagenase or trypsin but further contains hyaluronidase or a mixture of hyaluronidase and DNase I. The present disclosure also relates to use of the dissociation reagent in dispersing tumor tissues and detecting expression level of molecular markers on cell surface by flow cytometry. The dissociation reagent of the present disclosure does not cause degradation of molecular markers on cell surface such as CD8, PD-1, Tim-3, Lag-3 and the like, thus does not affect downstream assays.

Abstract: The present disclosure relates to a dissociation reagent for tumor tissues. The dissociation reagent does not contain collagenase or trypsin but further contains hyaluronidase or a mixture of hyaluronidase and DNase I. The present disclosure also relates to use of the dissociation reagent in dispersing tumor tissues and detecting expression level of molecular markers on cell surface by flow cytometry. The dissociation reagent of the present disclosure does not cause degradation of molecular markers on cell surface such as CD8, PD-1, Tim-3, Lag-3 and the like, thus does not affect downstream assays.

Abstract: Accordingly, there is provided a catalytic membrane comprising a porous substrate having a first surface and a second surface. The substrate has micropores, for example, pores ranging from about 10 .ANG. to about 2000 .ANG. in diameter, at least in a region extending from the first surface toward the second surface for a preselected distance. Preferably, the preselected distance will be sufficient to provide a measurable resistance to the flow of a fluid, such as a gas, through the micropores. A catalyst is deposited at least on the first surface of the substrate, although optionally, the catalyst is deposited on the substrate in the micorpore region. A transport layer is provided on the first surface of the substrate, including any catalyst on the first surface.